CSL signs deal with Trump administration to slash prices for its medicines
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
An unprecedented US deal allows private firm North American Blue Energy Partners (NABEP) to lease 17 Venezuelan oilfields containing approximately 65 billion barrels of oil reserves for 100 years. The US will receive a 35% equity stake in NABEP, guarantee a 20% share in oil production, and have first refusal on all remaining production.
Venezuelan businessman Alejandro Betancourt leads NABEP, whose ownership and activities have been under scrutiny by US and European authorities. Betancourt has denied allegations against him. Major oil companies, including ExxonMobil and ConocoPhillips, are hesitant to invest in Venezuela due to concerns about legal certainty and adherence to the rule of law with Betancourt involved.
Despite the red flags, Chevron, a major US oil producer in Venezuela, remains actively negotiating contracts for energy projects. Chevron aims to secure new blocks in the Orinoco Belt and explore new areas for diluent production. Other companies, such as Eni, ONGC, GeoPark, and GE Vernova, are also working on agreements in Venezuela.
Written by urgent.news from New Straits Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
